Prognostic factors in myelodysplastic syndromes: Critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques

British Journal of Haematology

Volumn 94, Issue 1, 1996, Pages 116-119

  Morel, Pierre ^a   Declercq, Christophe ^b   Hebbar, Mohamed ^c   Bauters, Francis ^c   Fenaux, Pierre ^c,d  

^a Centre Hospitalier de LENS   (France)

^b Observ Regionale de la S du Nord   (France)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Myelodysplastic syndromes; Prognostic factors; Standard mortality ratio

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ARTICLE; CHRONIC MYELOMONOCYTIC LEUKEMIA; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

EID: 0030056556     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.6122056.x     Document Type: Article

References (11)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D., Gralnick, G. & Sultan, C. (1992) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Breslow, N.E. & Day, N.E. (1985) The standardized mortality ratio. Biostatics: Statistics in Biomédical. Public Health and Environmental Sciences (ed. by P. K. Sen), p. 55. North Holland/Elsevier Science Publishers BV, New York.
3. Breslow, N.B., Lubin, J.H., Marek, P. & Langholz, B. (1993) Multiplicative models and cohort analysis. Journal of the American Statistical Association, 78, 1-12.
4. Ganser, A. & Hoelzer, D. (1992) Clinical course of myelodysplastic syndromes. Hematology and Oncology Clinics of North America. 6, 607-617.
5. Greenberg, P., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G., Bennett, J., Cox, C. & Le Beau, M. (1995) International workshop consensus risk analysis system for myelodysplastic syndromes (MDS). Blood, 86, (Suppl. 1), 270a.
6. Morel, P., Hebbar, M., Lai, J.L., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be included in new scoring systems: a report on 408 cases. Leukemia, 7, 1315-1324.
7. Mufti, G.J., Stevens, J.R., Oscier, D.G., Hamblin, T.J. & Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425-433.
8. Sanz, G.F., Sanz, M.A., Vallepsi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.
9. Wattel, E., Hecquet, B., Grahek, D., Hebbar, M., Morel, P., Lai, J.L., Bauters, F. & Fenaux, P. (1993) Long-term sunvivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors. Leukemia Research, 17, 733-739.
10. Worsley, A., Oscier, D.G., Stevens, J., Mufti, G. & Hamblin, T. (1988) Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. British Journal of Haematology, 68, 17-21.
11. Yoshida, Y., Oguma, S. & Uchimo, H. (1992) Clinical features of long-term survivors of refractory myelodysplastic anemias: a Japanese cooperative study. Leukemia Research, 8, 775-779.